Phase II Study of Infusional Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma

被引：6
|
作者：
Lendvai, Nikoletta [1 ]
Landau, Heather [2 ]
Lesokhin, Alexander
Tsakos, Ioanna
Koehne, Guenther [3 ]
Chung, David [2 ]
Devlin, Sean
Hassoun, Hani [1 ]
Giralt, Sergio A. [4 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Myeloma Lymphoma Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplantat Serv, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Allogene Bone Marrow Transplant Serv, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Allogene Bone Marrow Transplantat Med, New York, NY 10021 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.947.947
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
947
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II study of carfilzomib in patients with relapsed/refractory multiple myeloma and renal insufficiency
    Badros, A. Z.
    Vij, R.
    Martin, T.
    Zonder, J. A.
    Wong, A. F.
    Woo, T.
    Boussina, K.
    Wang, Z.
    Niesvizky, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma
    Berdeja, Jesus G.
    Hart, Lowell L.
    Mace, Joseph R.
    Arrowsmith, Edward R.
    Essell, James H.
    Owera, Rami S.
    Hainsworth, John D.
    Flinn, Ian W.
    [J]. HAEMATOLOGICA, 2015, 100 (05) : 670 - 676
  • [3] Phase II Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (PX-171-003)
    Jagannath, S.
    Vij, R.
    Stewart, A. K.
    Somlo, G.
    Jakubowiak, A.
    Reiman, T.
    Trudel, S.
    Taylor, J.
    Fuhrman, D.
    Cruickshank, S.
    Schwartz, R.
    Kunkel, L.
    Siegel, D.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S61 - S61
  • [4] PHASE II STUDY OF CARFILZOMIB IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND VARYING DEGREES OF RENAL INSUFFICIENCY
    Niesvizky, R.
    Vij, R.
    Martin, T.
    Zonder, J.
    Boussina, K.
    Wang, Z.
    Woo, T.
    Wong, A.
    Badros, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 159 - 159
  • [5] A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma
    Watanabe, Takashi
    Tobinai, Kensei
    Matsumoto, Morio
    Suzuki, Kenshi
    Sunami, Kazutaka
    Ishida, Tadao
    Ando, Kiyoshi
    Chou, Takaaki
    Ozaki, Shuji
    Taniwaki, Masafumi
    Uike, Naokuni
    Shibayama, Hirohiko
    Hatake, Kiyohiko
    Izutsu, Koji
    Ishikawa, Takayuki
    Shumiya, Yoshihisa
    Kashihara, Tomohisa
    Iida, Shinsuke
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (05) : 745 - 756
  • [6] A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
    Hans C. Lee
    Jatin J. Shah
    Lei Feng
    Elisabet E. Manasanch
    Rebecca Lu
    Ashley Morphey
    Brandon Crumpton
    Krina K. Patel
    Michael L. Wang
    Raymond Alexanian
    Sheeba K. Thomas
    Donna M. Weber
    Robert Z. Orlowski
    [J]. Blood Cancer Journal, 9
  • [7] A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
    Lee, Hans C.
    Shah, Jatin J.
    Feng, Lei
    Manasanch, Elisabet E.
    Lu, Rebecca
    Morphey, Ashley
    Crumpton, Brandon
    Patel, Krina K.
    Wang, Michael L.
    Alexanian, Raymond
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    [J]. BLOOD CANCER JOURNAL, 2019, 9 (10)
  • [8] A Phase II Study of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for Relapsed or Refractory Multiple Myeloma
    Fiala, Mark A.
    Keller, Jesse
    Sekhar, Jeevan
    Ceriotti, Connie
    Abboud, Camille N.
    DiPersio, John F.
    Tomasson, Michael H.
    Wildes, Tanya M.
    Stockerl-Goldstein, Keith
    Vij, Ravi
    [J]. BLOOD, 2016, 128 (22)
  • [9] phase II study of daratumumab with weekly carfilzomib, pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma
    Yee, Andrew
    Nadeem, Omar
    Rosenblatt, Jacalyn
    Sperling, Adam
    Bianchi, Giada
    Munshi, Nikhil
    O'Donnell, Elizabeth
    Branagan, Andrew
    Avigan, David
    Liegel, Jessica
    Harrington, Cynthia
    Agyemang, Emerentia
    Lively, Kathleen
    Packer, Lisette
    Han, Samuel
    Minsky, Cole
    Riadi, Manal
    Mcvey, Cailin
    Donnelly, Kaleigh
    Smith, Caitlin
    Katzeff, Mackenna
    Goguen, Amy
    Horick, Nora
    Richardson, Paul
    Raje, Noopur
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S220 - S221
  • [10] Carfilzomib In Relapsed, or Relapsed and Refractory, Multiple Myeloma
    McCormack, Paul L.
    [J]. DRUGS, 2012, 72 (15) : 2023 - 2032
12345